Emil Von Behring

Also found in: Wikipedia.

Behring, Emil Von


Born Mar. 15, 1854, in Hansdorf; died Mar. 31, 1917, in Marburg. German bacteriologist.

Behring graduated from the Medical Institute in Berlin in 1880. He worked as a military physician from 1881 to 1889 and served as assistant to R. Koch at the Hygiene Institute at the University of Berlin from 1889 to 1895. He was named professor of hygiene in Halle in 1894, and beginning in 1895 he served as director and professor at the Hygiene Institute that he founded in Marburg.

Behring’s main works are devoted to the treatment and prevention of infectious diseases. Together with Shibasaburo Kitazato he discovered the medicinal effect of immunizing serums for diphtheria and tetanus and also developed the theory of serotherapy. Behring discovered that a toxin exerts an enhanced effect when administered in a stepwise manner.

Behring won a Nobel Prize in 1901.


Die Blutserumtherapie, [vols.] 1–2. Liepzig, 1892.
Ätiologie und ätiologische Therapie des Tetanus. Berlin, 1904.
Einfuhrung in die Lehre von der Bekämpfung der Infektionskrankheiten. Berlin, 1912.
References in periodicals archive ?
Indeed, on his death, at least one headline referred to him as "the merchant of death." The winners that first year included, among others, Wilhelm Rontgen in physics, for the discovery of X-rays; Emil von Behring, in medicine, for his work on serum therapy for diphtheria; and Henry Dunant, founder of the International Committee of the Red Cross.
(1) Department of Pneumology, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
Un buen ejemplo, en el dominio de la microbiologia, podria ser el de Shibasaburo Kitasato (1852-1931), estrecho colaborador en Alemania de Emil von Behring (1854-1917) en el descubrimiento y desarrollo de las antitoxinas: solo el segundo investigador se eponimizo en la ley de Behring, y solo el recibio el primer premio Nobel de Medicina, en 1901, "por sus trabajos sobre seroterapia, especialmente su aplicacion contra la difteria, por la cual ha abierto [en singular] un nuevo camino en el campo de la ciencia medica colocando en manos del medico un arma victoriosa contra la enfermedad y la muerte" [1].
Since the early studies of Emil von Behring and Kitasato Shibasaburo 125 years ago, describing the presence of neutralizing proteins in blood and their effectiveness in controlling infections (which led to the first serum treatment against diphtheria and tetanus), antibodies have been an essential component in biomedical research.
The four authors and their affiliations are as follows: Robert Loddenkemper (HELIOS-Klinikum Emil von Behring, Berlin, Germany), Praveen N.
In 1901 his work on serum therapy won Emil von Behring the first-ever what?
By 1890, Ehrlich decided to focus its attention on the nascent field of immunology, thanks to the invitation that Robert Koch made to him to work in the newly created Institute of Infectious Diseases in Berlin, where Emil von Behring recently had discovered the antitoxins against tetanus and diphtheria.
Students pursuing their bachelor's degree in an accredited clinical laboratory science program may apply for one of 34 scholarships of $2,500 each through the Emil von Behring Scholarship Program, named after the 1901 Nobel prize recipient, and administered by the American Society for Clinical Pathology (ASCP) ["Scholarship moves MLT toward dream to help Sudan," MLO, November 2005, p.
This discovery was instrumental to the development of antitoxin by Emil von Behring in 1890, for which Behring won the first ever Nobel Prize for physiology or medicine.
Koch attracted an exceptional team of workers, such as August von Wasserman, Paul Ehrlich, Richard Pfeiffer, Emil von Behring, Shibasaburo Kitasato, Friedrich Loeffler, and Georg Gaffky, all of whom made their own mark in medicine.
In 1890, in work that later won him a Nobel prize, the German scientist Emil von Behring successfully immunized rabbits and mice against tetanus and diphtheria, two serious illnesses that commonly afflicted people.